Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> ABBVIE Latest News

6 HOURS AGO - Wall Street Journal

A Must Read - Share

New Hepatitis C Drug Gets Helping Hand

Express Scripts will make an AbbVie drug the exclusive option for patients with the most common form of hepatitis C. The move will help the drug maker take market share from Gilead, maker of Sovaldi.

Tags: New Hepatitis C Drug Gets Helping Hand,  Abbvie Latest News

DEC 19, 2014 - Associated Press

A Must Read - Share

FDA approves AbbVie combo hepatitis C treatment

TRENTON, N.J. (AP) — Patients with chronic hepatitis C have a new option for treating the liver-damaging virus, with the approval of a combination treatment developed by AbbVie.

Tags: FDA approves AbbVie combo hepatitis C treatment,  Abbvie Latest News

DEC 19, 2014 - New York Times

A Must Read - Share

AbbVie Wins Approval of Hepatitis C Treatment

Insurers are hoping that a new competitor to Gilead Sciences’ drugs for the disease will drive down prices.

Tags: AbbVie Wins Approval of Hepatitis C Treatment,  Abbvie Latest News

DEC 19, 2014 - ABC News

A Must Read - Share

FDA Approves AbbVie Combo Hepatitis C Treatment

FDA approves AbbVie combo hepatitis C treatment, part of wave of better, less-toxic options

Tags: FDA Approves AbbVie Combo Hepatitis C Treatment,  Abbvie Latest News

DEC 18, 2014 - TheStreet

A Must Read - Share

2014 Healthcare Stock Report Card: Sobek Tracks His Hits and Misses

NEW YORK (TheStreet) -- The year is just about over, so here is a final report card on my 2014 healthcare stock predictions: "The launch of Gilead Sciences'   hepatitis C drug Sovaldi will be tremendously strong in early 2014, propelling the company's market value past Merck . However, sofosbuvir's sales growth will slow later in the year, raising investor concerns ...

Tags: 2014 Healthcare Stock Report Card: Sobek Tracks His Hits and Misses,  Abbvie Latest News